Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5252)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsaitas C, Semertzidou A, Sinakos E. Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol 2014; 6(4): 178-187 [PMID: 24799986 DOI: 10.4254/wjh.v6.i4.178] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i4/178.htm |
| Number | Citing Articles |
| 1 |
M. Safaeian, H.A. Robbins, S.I. Berndt, C.F. Lynch, J.F. Fraumeni, E.A. Engels. Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. American Journal of Transplantation 2016; 16(3): 960 doi: 10.1111/ajt.13549
|
| 2 |
Yuki Horio, Motoi Uchino, Toshihiro Bando, Teruhiro Chohno, Hirofumi Sasaki, Akihiro Hirata, Yoshio Takesue, Hiroki Ikeuchi. Rectal-sparing type of ulcerative colitis predicts lack of response to pharmacotherapies. BMC Surgery 2017; 17(1) doi: 10.1186/s12893-017-0255-5
|
| 3 |
Fotios S. Fousekis, Konstantinos H. Katsanos, Vasileios I. Theopistos, Gerasimos Baltayiannis, Maria Kosmidou, Georgios Glantzounis, Leonidas Christou, Epameinondas V. Tsianos, Dimitrios K. Christodoulou. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0967-3
|
| 4 |
Jessica R. Allegretti, Zain Kassam, Madeline Carrellas, Benjamin H. Mullish, Julian R. Marchesi, Alexandros Pechlivanis, Mark Smith, Ylaine Gerardin, Sonia Timberlake, Daniel S. Pratt, Joshua R. Korzenik. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. American Journal of Gastroenterology 2019; 114(7): 1071 doi: 10.14309/ajg.0000000000000115
|
| 5 |
Lars Aabakken, Tom H. Karlsen, Jörg Albert, Marianna Arvanitakis, Olivier Chazouilleres, Jean-Marc Dumonceau, Martti Färkkilä, Peter Fickert, Gideon M. Hirschfield, Andrea Laghi, Marco Marzioni, Michael Fernandez, Stephen P. Pereira, Jürgen Pohl, Jan-Werner Poley, Cyriel Y. Ponsioen, Christoph Schramm, Fredrik Swahn, Andrea Tringali, Cesare Hassan. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Journal of Hepatology 2017; 66(6): 1265 doi: 10.1016/j.jhep.2017.02.013
|
| 6 |
Junjie Liu, Ping Xue, Jingwen Deng. Therapeutic effect of photodynamic therapy for nonresectable cholangiocarcinoma. Medicine 2018; 97(8): e9863 doi: 10.1097/MD.0000000000009863
|
| 7 |
Gianluca Rompianesi, Reena Ravikumar, Sophie Jose, Michael Allison, Anuja Athale, Felicity Creamer, Bridget Gunson, Derek Manas, Andrea Monaco, Darius Mirza, Nicola Owen, Keith Roberts, Gourab Sen, Parthi Srinivasan, Stephen Wigmore, Giuseppe Fusai, Bimbi Fernando, Andrew Burroughs, Emmanuel Tsochatzis. Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients. Liver International 2019; 39(2): 353 doi: 10.1111/liv.13947
|
| 8 |
Pilar López Serrano, Juan Turnes Vázquez. Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity. Revista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.7512/2020
|
| 9 |
Ayumi Ito, Shun Murasugi, Maria Yonezawa, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige. A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis. Journal of Clinical Apheresis 2024; 39(1) doi: 10.1002/jca.22099
|
| 10 |
Masakazu Yashiro. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(8): 2251 doi: 10.1007/s10620-015-3646-4
|
| 11 |
Daniel H. Ahn, Tanios Bekaii-Saab. Textbook of Gastrointestinal Oncology. 2019; : 185 doi: 10.1007/978-3-030-18890-0_11
|
| 12 |
T.J. Weismüller, T.O. Lankisch, T. Voigtländer. Kolonkarzinom und Gallengangskarzinom bei primär sklerosierender Cholangitis. Der Gastroenterologe 2015; 10(1): 26 doi: 10.1007/s11377-014-0941-0
|
| 13 |
Jeremy S Nayagam, Stephen P Pereira, John Devlin, Phillip M Harrison, Deepak Joshi. Controversies in the management of primary sclerosing cholangitis. World Journal of Hepatology 2016; 8(5): 265-272 doi: 10.4254/wjh.v8.i5.265
|
| 14 |
Blair Fennimore, Emilie H. Regner, Mark E. Gerich. Primary Sclerosing Cholangitis. 2017; : 29 doi: 10.1007/978-3-319-40908-5_3
|
| 15 |
Alireza Rezaee, Rathan M. Subramaniam, Markus Raderer, Werner Langsteger, Mohsen Beheshti. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging. 2018; : 127 doi: 10.1016/B978-0-323-48567-8.00007-9
|
| 16 |
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1): 39 doi: 10.21508/1027-4065-2021-66-1-39-46
|
| 17 |
Leona Dold, Leonie Frank, Philipp Lutz, Dominik J. Kaczmarek, Benjamin Krämer, Jacob Nattermann, Tobias J. Weismüller, Vittorio Branchi, Marieta Toma, Maria Gonzalez-Carmona, Christian P. Strassburg, Ulrich Spengler, Bettina Langhans. IL-6–Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing Cholangitis. Clinical and Translational Gastroenterology 2023; 14(8): e00603 doi: 10.14309/ctg.0000000000000603
|
| 18 |
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. BIOCELL 2021; 45(3): 461 doi: 10.32604/biocell.2021.014332
|
| 19 |
Giulia Santi, Pierre Michetti, Florian Froehlich, Jean-Benoît Rossel, Valérie Pittet, Michel H. Maillard. Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis. Inflammatory Intestinal Diseases 2021; 6(1): 25 doi: 10.1159/000511010
|
| 20 |
David L. Suskind, Bicong Wu, Kim Braly, M. Cristina Pacheco, Ghassan Wahbeh, Dale Lee. Clinical Remission and Normalization of Laboratory Studies in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis Using Dietary Therapy. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(1) doi: 10.1097/MPG.0000000000001966
|
| 21 |
Robert van Vorstenbosch, Kim van Munster, Georgios Stavropoulos, Daniëlle Pachen, Frederik-Jan van Schooten, Cyriel Ponsioen, Agnieszka Smolinska. The potential of volatile organic compounds to diagnose primary sclerosing cholangitis. JHEP Reports 2024; 6(8): 101103 doi: 10.1016/j.jhepr.2024.101103
|
| 22 |
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
|
| 23 |
Adnan Malik, Ani A. Kardashian, Kais Zakharia, Christopher L. Bowlus, James H. Tabibian. Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist. Liver Research 2019; 3(2): 118 doi: 10.1016/j.livres.2019.04.001
|
| 24 |
Brian M Fung, Keith D Lindor, James H Tabibian. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World Journal of Gastroenterology 2019; 25(6): 659-671 doi: 10.3748/wjg.v25.i6.659
|
| 25 |
Tze Sheng Khor, Till S. Claudtiz, Bence Kővári, Gregory Y. Lauwers, Michael B. Wallace, Priyanthi Kumarasinghe. Gastrointestinal Pathology. 2021; : 235 doi: 10.1002/9781119073048.ch10
|
| 26 |
Hannah Bloemen, Alexandra E. Livanos, Adrielly Martins, Richard Dean, Ana Catarina Bravo, Arno R. Bourgonje, Michael Tankelevich, Jake Herb, Judy Cho, André Anastácio Santos, Cecília M.P. Rodrigues, Francesca Petralia, Jean-Frederic Colombel, Christopher L. Bowlus, Thomas Schiano, Joana Torres, Cynthia Levy, Saurabh Mehandru. Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity. Clinical Gastroenterology and Hepatology 2024; doi: 10.1016/j.cgh.2024.10.005
|
| 27 |
Takeshi Makiuchi, Tomotaka Sobue, Tetsuhisa Kitamura, Junko Ishihara, Norie Sawada, Motoki Iwasaki, Shizuka Sasazuki, Taiki Yamaji, Taichi Shimazu, Shoichiro Tsugane. Association between green tea/coffee consumption and biliary tract cancer: A population‐based cohort study in Japan. Cancer Science 2016; 107(1): 76 doi: 10.1111/cas.12843
|
| 28 |
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 2018; 12(1): 17 doi: 10.5009/gnl16510
|
| 29 |
Zi-Ying Lin, Zhen-Xing Liang, Pei-Lin Zhuang, Jie-Wei Chen, Yun Cao, Li-Xu Yan, Jing-Ping Yun, Dan Xie, Mu-Yan Cai. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2827-7
|
| 30 |
Juan Octavio Alonso Lárraga, José Miguel Jiménez-Gutiérrez, Marcos Meneses-Mayo, Angélica Hernández-Guerrero , Mónica Lizzette Serrano-Arévalo, Lidia Faridi Villegas-González. Acceptable Number of Cholangioscopy-guided Biopsies for Diagnosing Perihilar Cholangiocarcinoma. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.10719/2024
|
| 31 |
Heather N. Hartman, Julie Niemela, Mary K. Hintermeyer, Mary Garofalo, Jennifer Stoddard, James W. Verbsky, Sergio D. Rosenzweig, John M. Routes. Gain of Function Mutations of PIK3CD as a Cause of Primary Sclerosing Cholangitis. Journal of Clinical Immunology 2015; 35(1): 11 doi: 10.1007/s10875-014-0109-1
|
| 32 |
Peter Fickert. Bad memories from the gut may cause nightmares for the bile ducts. Journal of Hepatology 2017; 66(1): 5 doi: 10.1016/j.jhep.2016.09.016
|
| 33 |
Dongqing Gu, Min Zhang, Yutong Wang, Ye Bai, Xin Wang, Guohong Deng. Causal effect of autoimmune liver diseases on cancer: Meta‐analyses of cohort studies and Mendelian randomization study. Liver International 2022; 42(10): 2216 doi: 10.1111/liv.15355
|
| 34 |
Lelde Lauka, Giulio Vitali, Thierry Berney, Nicola de’Angelis. Emergency Surgical Management of Colorectal Cancer. Hot Topics in Acute Care Surgery and Trauma 2019; : 189 doi: 10.1007/978-3-030-06225-5_17
|
| 35 |
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
|
| 36 |
Federica Ferrari, Giusy Ranucci, Marina Aloi, Luca Della Volpe, Franca Viola, Erasmo Miele, Salvatore Cucchiara, Raffaele Iorio. A promising medium‐term follow‐up of pediatric sclerosing cholangitis: Mild phenotype or early diagnosis?. Hepatology Research 2018; 48(7): 556 doi: 10.1111/hepr.13059
|
| 37 |
Pamela L. Valentino, Shanna Wiggins, Sarah Harney, Roshan Raza, Christine K. Lee, Maureen M. Jonas. The Natural History of Primary Sclerosing Cholangitis in Children. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(6): 603 doi: 10.1097/MPG.0000000000001368
|
| 38 |
Keith D Lindor, Kris V Kowdley, Edwyn M Harrison. ACG Clinical Guideline: Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2015; 110(5): 646 doi: 10.1038/ajg.2015.112
|
| 39 |
Deborah Saraggi, Matteo Fassan, Claudia Mescoli, Marco Scarpa, Nicola Valeri, Andrea Michielan, Renata D’Incá, Massimo Rugge. The molecular landscape of colitis-associated carcinogenesis. Digestive and Liver Disease 2017; 49(4): 326 doi: 10.1016/j.dld.2016.12.011
|
| 40 |
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Choledochoscopy: An update. World Journal of Gastrointestinal Endoscopy 2021; 13(12): 571-592 doi: 10.4253/wjge.v13.i12.571
|
| 41 |
Harveen Singh, Fariha Balouch, Charlton Noble, Peter Lewindon. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(1): 80 doi: 10.1097/MPG.0000000000001927
|
| 42 |
Richard M. Gore, Jonathan W. Berlin, Aleksandar M. Ivanovic. Textbook of Gastrointestinal Radiology, 2-Volume Set. 2015; : 984 doi: 10.1016/B978-1-4557-5117-4.00057-X
|
| 43 |
Takeshi Makiuchi, Tomotaka Sobue, Tetsuhisa Kitamura, Norie Sawada, Motoki Iwasaki, Shizuka Sasazuki, Taiki Yamaji, Taichi Shimazu, Shoichiro Tsugane. Reproductive factors and gallbladder/bile duct cancer: a population-based cohort study in Japan. European Journal of Cancer Prevention 2017; 26(4): 292 doi: 10.1097/CEJ.0000000000000260
|
| 44 |
Koji Tanaka, Toshimitsu Araki, Yuji Toiyama, Yoshiki Okita, Yasuhiko Mohri, Masato Kusunoki. Colitis-Associated Cancer. 2016; : 23 doi: 10.1007/978-4-431-55522-3_2
|
| 45 |
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
|